South Korean digital health pioneer, Huinno, has announced the successful initiation of the first commercial rollout for its innovative AI-based telemetry system, Memo Cue. This significant milestone was achieved on Tuesday at H Plus Yangji Hospital, marking a strategic partnership with Yuhan Corporation.
This advanced AI-driven patient monitoring system is now deployed across approximately 100 beds within departments at H Plus Yangji Hospital, a 300-bed facility renowned for its integrated nursing care system. This deployment specifically targets areas requiring continuous cardiac monitoring, enhancing patient oversight.
Memo Cue revolutionizes patient safety by providing real-time analysis of hospitalized patients’ electrocardiogram (ECG) data. This capability ensures early detection of cardiac abnormalities, facilitating quicker, more informed clinical decision-making. Crucially, the system expands continuous patient monitoring from intensive care units (ICUs) into general wards, significantly elevating overall patient safety management.
Designed for seamless integration, Memo Cue operates on a highly efficient wireless setup. This innovative approach leverages existing hospital communication infrastructure, dramatically reducing both the cost and complexity typically associated with installing advanced monitoring systems.
Central to the Memo Cue solution is the compact and highly reliable wearable ECG device, Memo Patch M. Engineered for critical situations, it features a robust defibrillation protection circuit, guaranteeing continuous monitoring even during emergencies. This state-of-the-art device efficiently delivers over 99 percent of defibrillation energy to the patient, critically resuming ECG measurement within a mere five seconds post-defibrillation.
Underscoring its commitment to patient safety and quality, Memo Patch M secured 510(k) clearance from the US Food and Drug Administration (FDA) in December. Furthermore, it adheres to the industry’s most stringent electrical safety classification, achieving “Type CF Defib-proof” status under the rigorous IEC 60601-1 standards.
A representative from H Plus Yangji Hospital highlighted the immediate benefits of the system, stating that Memo Cue allows for rapid deployment without requiring additional hospital infrastructure. They further emphasized its role in significantly reducing the workload and fatigue of medical staff by providing critical real-time patient monitoring capabilities.
Huinno CEO Gil Yeong-joon underscored the significance of this initial deployment, remarking, “This rollout marks the first commercial application of Memo Cue, and we are strategically poised to expand its adoption across major hospitals nationwide, continuing our strong partnership with Yuhan Corporation.”
jwjeon7625
